Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Donate BTC or other Cryptocurrency
Your donation supports practical, accurate info about psychoactive
plants & drugs. We accept 9 cryptocurrencies. Contribute a bit today!
DMT Journal Articles & Abstracts


General
Pharmacology
Biology
Presence in Mammals

GENERAL

Profiles of Psychedelic Drugs: DMT, by Alexander T. Shulgin, PhD
Journal of Psychedelic Drugs, Vol 8 (No. 2) Apr-Jun 1976, 167-168
(Online Copy)(Hardcopy)

Programmed Communication During Experiences With DMT, by Timothy Leary
Psychedelic Review, No 8, 1966
(Online Copy)

The Psychedelic Model of Schizophrenia: The Case of N,N-Dimethyltryptamine, by Gillin, Kaplan, Stillman & Wyatt
American Journal of Psychiatry, Vol 133 (No. 2) Feb 1976, 203-208
(Excerpts)



	


PHARMACOLOGY

Human psychopharmacology of N,N-dimethyltryptamine, by R.J. Strassman
Behavioral Brain Res, Vol 73 (No. 1-2) 1996, 121-124
(Abstract)



	


BIOLOGY

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans., by R.J. Strassman; C.R. Qualls; L.M. Berg
Biological Psychiatry, Vol 39 (No. 9) May 1, 1996, 784-795
(Abstract)



	


PRESENCE IN MAMMALS

Biogenesis of 5-methoxy-N,N-dimethyltryptamine in human pineal gland. by Guchhait RB.
J Neurochem, 1976;26:187-90.


Tryptamine-N-methyltransferase activity in brain tissue: a re-examination. by Boarder MR, Rodnight R.
Brain Res, 1976;114:359-64.


Enzymatic N-methylation of indoleamines by mammalian brain: Fact or artefact? by Gomes UR, Neethling AC, Shanley BC.
J Neurochem, 1976;27:701-5.


Improved selective ion monitoring mass-spectrometric assay for determination of N,N-dimethyltryptamine in human blood utilizing capillary column gas chromatography. by Walker RW, Mandel LR, Kleinman JE, Gillin JC, Wyatt RJ, Vandenheuvel WJA.
J Chromatogr, Biomed Appl, 1979;162:539-46.


Tryptamine, N,N-dimethyltryptamine,N,N-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine. by Franzen F, Gross H.
Nature 1965;206:1052.


Psychotomimetic N-methylated tryptamines: Formation in brain in vivo and in vitro. by Saavedra JM, Axelrod J.
Science 1972;175:1365-6.


Increased excretion of dimethyltryptamine and certain features of psychosis. A possible association. by Murray RM, Oon MCH, Rodnight R, Birley JLT, Smith A.
Arch Gen Psychiatry, 1979;36:644-9.


A dimethyltryptamine-forming enzyme in human blood. by Wyatt RJ, Saavedra JM, Axelrod J.
Am J Psychiatry 1973;130:754-60.


N,N-Dimethyltryptamine: An endogenous hallucinogen. by Barker SA, Monti JA, Christian ST.
Int Rev Neurobiol 1981;22:83-110.


Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients. by Wyatt RJ, Mandel LR, Ahn HS, Walker RW, Vandenheuvel WJA.
Psychopharmacology, 1973;31:265-70.


Blood dimethyltryptamine concentrations in psychotic disorders. by Lipinski JF, Mandel LR, Ahn HS, Vandenheuvel WJA, Walker RW.
Biol Psychiatry, 1974;9:89-91.


The enzymatic N-methylation of serotonin and other amines. by Axelrod J.
J Pharmacol Exp Ther, 1962;138:28-33.


The distribution and properties of the non-specific N-methyltransferase in brain. by Saavedra JM, Coyle JT, Axelrod J.
J Neurochem 1973;20:743-52.


Urinary excretion of dimethyltryptamine in liver disease. by Checkley SA, Oon MCH, Rodnight R, Murphy MP, Williams RS, Birley JLT.
Am J Psychiatry, 1979;136:439-41.


Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations. by Corbett L, Christian ST, Morin RD, Benington F, Smythies JR.
Br J Psychiatry 1978;132:139-44.


In: Wood J, ed. Neurobiology of Cerebrospinal Fluid. v. 2. by Brown G, Smythies J, Morin R.
New York: Plenum, 1983:173-7.


Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry. by Smythies JR, Morin RD, Brown G.
Biol Psychiatry 1979;14:549-56.


biosignificance of n- and o-methylated indoles to psychiatric disorders. by Koslow.
National Institute of Mental Health, 1974;23:210-9.


Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects. by Oon MCH, Murray RM, Rodnight R, Murphy MP, Birley JLT.
Psychopharmacology, 1977;54:171-5.


A proposed mechanism for the visions of dream sleep. by Callaway J.
Medical Hypotheses, 1988;26:119-24.